Ignite Creation Date:
2024-05-06 @ 7:46 PM
Last Modification Date:
2024-10-26 @ 3:14 PM
Study NCT ID:
NCT06136585
Status:
RECRUITING
Last Update Posted:
2024-07-01
First Post:
2023-11-13
Brief Title:
Sugammadex Vs Neostigmine in Reversing Neuromuscular Blocks in Outpatient ERCP A Randomized Double-Blinded Trial
Sponsor:
The Cleveland Clinic
Organization:
The Cleveland Clinic
Organization Data
Organization:
The Cleveland Clinic
Class:
OTHER
Study ID:
23-378
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
The Cleveland Clinic
Lead Sponsor Class:
OTHER
Responsible Party:
Ryu Komatsu
Responsible Party Title:
MD
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
The Cleveland Clinic
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck Sharp Dohme LLC | INDUSTRY |